Novel therapies to limit renal fibrosis in diverse models of renal disease. Kidney failure is a devastating health, social and financial outcome for the individual, their employer, family and the broader society, This project will carefully dissect mechanisms underpinning the scarring in the kidney that predisposes to kidney failure and will investigate novel therapies to prevent kidney damage.
Probiotic Prophylaxis Of Spinal Cord Injury Urinary Tract-Infection TherapeUtic-Trial (ProSCIUTTU)
Funder
National Health and Medical Research Council
Funding Amount
$800,747.00
Summary
Urinary Tract Infections (UTI) are common in spinal cord injury (SCI) and about 2-year occur in SCI. Antibiotic resistance is also common in SCI. UTI are harder to treat with high rates of antibiotic resistance and this often leads to hospitalisation with significant health and economic consequences to the SCI community and country. Probiotics may prevent UTI and treat people colonised with resistant organisms. Unlike alternatives like antibiotics, they do not worsen antibiotic resistance.
The role of SGK-1 and SGK-2 in hypertension and nephropathy in diabetes mellitus. The key objective is to define the suitability of the serum glucocorticoid regulated kinases -1 and -2 (SGK-1, -2) as novel drug discovery targets. A specific inhibitor targeting SGK-1 and -2 will be tested to determine if it reverses the enhanced sodium reabsorption and extracellular matrix production characteristic of progressive renal failure in in vitro models models of renal disease. These inhibitors present a ....The role of SGK-1 and SGK-2 in hypertension and nephropathy in diabetes mellitus. The key objective is to define the suitability of the serum glucocorticoid regulated kinases -1 and -2 (SGK-1, -2) as novel drug discovery targets. A specific inhibitor targeting SGK-1 and -2 will be tested to determine if it reverses the enhanced sodium reabsorption and extracellular matrix production characteristic of progressive renal failure in in vitro models models of renal disease. These inhibitors present an opportunity to control hypertension whilst simultaneously limiting fibrosis in the kidney. Renal failure is steadily increasing and is now the single largest health care cost to the community. These studies will provide the proof of concept required to ultimately bring this novel preventative therapy to the community.Read moreRead less
Can Exercise Delay Transition To Active Therapy In Men With Low Grade Prostate Cancer? A Multi-Centre Randomized Controlled Trial.
Funder
National Health and Medical Research Council
Funding Amount
$604,429.00
Summary
Prostate cancer overdiagnosis is associated with increased rates of overtreatment and associated morbidity. Although nearly half of Australian men diagnosed with low risk prostate cancer are managed with active surveillance there are no established recommendations for slowing disease progression and delaying transition to active treatment. The proposed study would be the first to determine the efficacy of a comprehensive exercise program during active surveillance for prostate cancer.
A Novel One-step Approach In The Early Diagnosis Of Prostate Cancer
Funder
National Health and Medical Research Council
Funding Amount
$102,150.00
Summary
In order to avoid the invasiveness and imprecision of current prostate cancer detection, this programme is directed to developing a non-invasive and repeatable, accurate approach. This research project is designed to optimise retrieval of prostate cells from ejaculate and to compare two methods for profiling selected genetic changes to diagnose prostate cancer. The refinement of techniques, outlined in the application, is essential before proceeding to a clinical trial.
The Concerted Actions Of Estrogen, ERa And Mast Cells In The Development Of Prostatitis And Prostate Cancer.
Funder
National Health and Medical Research Council
Funding Amount
$365,126.00
Summary
Inflammation of the prostate (prostatitis) is exceedingly common. As inflammation has been linked to the development of cancer the prevalence of prostatitis is a significant health issue. Estrogens may cause inflammation, although how this occurs remains unknown. Mast cells may be involved and this study will examine how these cells and estrogen promote prostatitis and prostate cancer. This work will provide vital information to develop better treatments of prostatitis and prostate cancer.